Interim Results in ALLOB Phase IIA Spinal Fusion Study
Interim results in a Phase IIA trial with Bone Therapeutics’ ALLOB® show evidence of successful spinal fusion and statistically significant improvements at 12 months. Sep 14, 2017
Bioventus Enrolls Patients in EXOGEN Trial
Bioventus enrolled first patients in BONES, the Bioventus Observational Non-interventional EXOGEN® Studies program, investigating the mitigation of nonunion. Sep 14, 2017
Xtant Medical Receives FDA Clearance for Expanded Indications of Irix-A
Xtant Medical received FDA 510(k) clearance to market line extensions for the Irix-A standalone interbody spacer. Sep 13, 2017
NuVasive Launches LessRay Software
NuVasive launched LessRay®, hardware and software designed to minimize overexposure to radiation in the O.R. Sep 13, 2017
Cerapedics 2-Year Follow-Up Data on i-FACTOR Bone Graft in the Cervical Spine
Follow-up data from an IDE clinical trial of Cerapedics’ i-FACTOR™ bone graft indicated statistical superiority to autograft in ACDF. Sep 12, 2017
Implanet Gains FDA Clearance for JAZZ Passer
IMPLANET received FDA 510(k) clearance to market JAZZ™ Passer, a system of spinal instruments and braided band technology. Sep 12, 2017
Ten-Year Results with Arthrosurface HemiCAP Toe
Ten-year follow-up data indicate excellent outcomes from use of the Arthrosurface HemiCAP resurfacing implant in the treatment of hallux rigidus. Sep 12, 2017
Zimmer Biomet Launches Persona Partial Knee
Zimmer Biomet commenced global launch of the Persona® Partial Knee. Sep 11, 2017
DePuy Synthes Launches TRUMATCH for Facial Reconstruction
DePuy Synthes announced the upcoming U.S. launch of TRUMATCH® Titanium 3D-Printed Implants for facial reconstruction. Sep 11, 2017
Spinal Resources’ FDA Clearance of Swedge Pedicle Screw
Spinal Resources received FDA 510(k) clearance to market the Swedge™ Pedicle Screw system. Sep 07, 2017
